ELANE and chronic obstructive pulmonary disease: However, in COPD, this protease–anti-protease stability is disrupted and affects lung damage [168]; protease-inhibitors imbalance is enhanced by a decrease in antiproteases such as α1-protease, neutrophil elastase, and leukocyte protease inhibitors and secretory proteinase inhibitors, which are inactivated by oxidants.